These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30976400)

  • 1. Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome.
    Cortazar FB; Rosenthal J; Laliberte K; Niles JL
    Clin Kidney J; 2019 Apr; 12(2):224-231. PubMed ID: 30976400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of rituximab in adult frequent-relapsing or steroid-dependent minimal change disease or focal segmental glomerulosclerosis: a systematic review and meta-analysis.
    Xue C; Yang B; Xu J; Zhou C; Zhang L; Gao X; Dai B; Yu S; Mao Z; Mei C; Xu C
    Clin Kidney J; 2021 Apr; 14(4):1042-1054. PubMed ID: 34094516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy in children with primary nephrotic syndrome: single center experience, Karachi, Pakistan.
    Moorani KN; Hotchandani HM; Zubair AM; Lohana NC; Veerwani NR
    BMC Nephrol; 2019 Jul; 20(1):239. PubMed ID: 31269922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome.
    Ruggenenti P; Ruggiero B; Cravedi P; Vivarelli M; Massella L; Marasà M; Chianca A; Rubis N; Ene-Iordache B; Rudnicki M; Pollastro RM; Capasso G; Pisani A; Pennesi M; Emma F; Remuzzi G;
    J Am Soc Nephrol; 2014 Apr; 25(4):850-63. PubMed ID: 24480824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up.
    Zonozi R; Laliberte K; Huizenga NR; Rosenthal JK; Jeyabalan A; Collins AB; Cortazar FB; Niles JL
    Am J Kidney Dis; 2021 Dec; 78(6):793-803. PubMed ID: 34174365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the Role of Rituximab in the Management of Adult Minimal Change Disease and Immune-Mediated Focal and Segmental Glomerulosclerosis.
    Aslam A; Koirala A
    Glomerular Dis; 2023; 3(1):211-219. PubMed ID: 37901702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS.
    Osterholt T; Todorova P; Kühne L; Ehren R; Weber LT; Grundmann F; Benzing T; Brinkkötter PT; Völker LA
    Sci Rep; 2023 Apr; 13(1):6980. PubMed ID: 37117201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab in Steroid-Dependent Podocytopathies.
    Costa C; Antunes A; Oliveira J; Pereira M; Godinho I; Fernandes P; Jorge S; Lopes JA; Gameiro J
    Glomerular Dis; 2024; 4(1):129-136. PubMed ID: 39144474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases.
    Kronbichler A; König P; Busch M; Wolf G; Mayer G; Rudnicki M
    Wien Klin Wochenschr; 2013 Jun; 125(11-12):328-33. PubMed ID: 23624956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
    Hansrivijit P; Cheungpasitporn W; Thongprayoon C; Ghahramani N
    BMC Nephrol; 2020 Apr; 21(1):134. PubMed ID: 32293308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome.
    Sinha A; Bhatia D; Gulati A; Rawat M; Dinda AK; Hari P; Bagga A
    Nephrol Dial Transplant; 2015 Jan; 30(1):96-106. PubMed ID: 25121488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in treatment of collapsing FSGS-A case series.
    Girimaji N; Bharati J; Nada R; Rathi M; Kohli HS; Ramachandran R
    Nephrology (Carlton); 2021 Feb; 26(2):134-141. PubMed ID: 32662534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in maintaining remission in adults with podocytopathy.
    Ramachandran R; Bharati J; Nada R; Minz R; Kohli HS
    Nephrology (Carlton); 2020 Aug; 25(8):616-624. PubMed ID: 32297386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.
    Ramachandran R; Kumar V; Rathi M; Nada R; Jha V; Gupta KL; Sakhuja V; Kohli HS
    Nephrol Dial Transplant; 2014 Oct; 29(10):1918-24. PubMed ID: 24771498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal segmental glomerular sclerosis can be effectively treated using an intensive B-cell depletion therapy.
    Roccatello D; Baffa A; Naretto C; Barreca A; Cravero R; Roscini E; Sciascia S; Fenoglio R
    Clin Kidney J; 2023 Aug; 16(8):1258-1264. PubMed ID: 37529640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T; Burst V; Teschner S; Benzing T; Kurschat CE
    Nephron Clin Pract; 2012; 120(2):c79-85. PubMed ID: 22286071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab treatment for relapsing minimal change disease and focal segmental glomerulosclerosis: a systematic review.
    Kronbichler A; Kerschbaum J; Fernandez-Fresnedo G; Hoxha E; Kurschat CE; Busch M; Bruchfeld A; Mayer G; Rudnicki M
    Am J Nephrol; 2014; 39(4):322-30. PubMed ID: 24751753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent CD-19 depletion by rituximab is cost-effective in maintaining remission in calcineurin-inhibitor dependent podocytopathy.
    Ramachandran R; Bharati J; Rao I; Kashif AW; Nada R; Minz R; Gupta KL; Kohli HS
    Nephrology (Carlton); 2019 Dec; 24(12):1241-1247. PubMed ID: 30586217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab therapy for refractory steroid-resistant nephrotic syndrome in children.
    Kamei K; Ishikura K; Sako M; Ito S; Nozu K; Iijima K
    Pediatr Nephrol; 2020 Jan; 35(1):17-24. PubMed ID: 30564879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.